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Abstract
Background. Lead-dependent infective endocarditis (LDIE) is a life-threatening complication of perma-
nent transvenous cardiac pacing. According to the 2015 European Society of Cardiology (ECS) guidelines, 
the diagnosis of LDIE is based on the modified Duke criteria (MDC), while single-photon emission computed 
tomography with conventional computed tomography (SPECT-CT) with radioisotope-labeled leukocytes 
serves as an additional tool in difficult cases. The major challenge is to differentiate between true vegetation 
and a thrombus.
Objectives. The aim of the study was to evaluate the usefulness of SPECT-CT with radioisotope-labeled 
leukocytes in diagnosing LDIE in patients with intracardiac masses (ICMs).
Material and methods. The prospective registry included 40 consecutive patients admitted with an ICM 
on the lead and suspicion of LDIE. The confirmation or rejection of the LDIE diagnosis was made according 
to an algorithm based on the MDC. The cohort was divided into 2 groups: patients with definite and possible 
LDIE diagnoses based on the MDC (the LDIE-positive group), and patients with negative LDIE diagnoses ac-
cording to the MDC (the LDIE-negative group). All patients underwent SPECT-CT with radioisotope-labeled 
leukocytes. The diagnostic ability of SPECT-CT was compared to the gold standard MDC.
Results. The LDIE-positive group with diagnosis based on the MDC consisted of 19 patients (LDIE definite – 11; 
LDIE possible – 8). The LDIE diagnosis was rejected on the basis of the MDC in 21 patients. The SPECT-CT results 
were compared with the MDC results and showed 73.7% sensitivity, 81.0% specificity, 77.5% accuracy, 77.8% 
positive predictive value (PPV), 77.3% negative predictive value (NPV), likelihood ratio positive (LR+) 3.868, 
likelihood ratio negative (LR–) 0.325, and moderate agreement (κ = 0.548, p < 0.001). After the exclusion 
of 5 patients treated with antibiotics at the time of the SPECT-CT, LR+ and LR− improved to 5.250 and 0, 
respectively, and inter-test agreement amounted to almost perfect concordance (κ = 0.773, p < 0.001).
Conclusions. Single-photon emission computed tomography with conventional CT with radioisotope-
labeled leukocytes is a useful, efficient, single-step test for diagnosing LDIE.
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Introduction
Lead-dependent infective endocarditis (LDIE) is a life-
threatening complication of permanent transvenous cardi-
ac pacing occurring in the right side of the heart. The term 
was coined to underline the fact that LDIE is a unique 
disease process and a distinct entity in the wide spectrum 
of cardiac device-related infective endocarditis (CDRIE), 
in which inflammation is associated with various types 
of implantable devices.1 According to most of the available 
reports, LDIE is the major risk factor for mortality after 
transvenous lead extraction (TLE) procedures.2 The 2009 
guidelines of European Society of Cardiology (ESC) con-
cerning the prevention, diagnosis and treatment of infec-
tive endocarditis (IE) outlined straightforward criteria 
(the Duke criteria) that should be met in order to diagnose 
IE.3 The major criteria for diagnosing IE include positive 
blood cultures and echocardiographic findings charac-
teristic of IE, such as vegetation and abscess formation. 
To identify patients with indwelling endocardial leads, 
2 additional major criteria have been introduced: local 
signs of infection and pulmonary embolism.
Implementing the results of additional imaging inves-
tigations of the source of  infection – positron emission 
tomography/computed tomography (PET-CT) and single-
photon emission computed tomography with conventional 
computed tomography (SPECT-CT) with radioisotope-
labeled leukocytes – into the ESC guidelines and giving 
them the importance of major criteria may significantly 
improve the  diagnostic accuracy of  the  Duke criteria.4 
The role of nuclear medicine, according to the guidelines, 
is confined to the diagnosis of prosthetic valve endocardi-
tis. The authors of the guidelines mentioned that PET-CT 
and SPECT-CT have proven their role in the diagnosis of car-
diac implantable electronic devices (CIEDs), but the data 
is not sufficient for them to be included in the diagnostic 
criteria of the specific topic of IE on pacemaker or defibril-
lator leads.4 Notably, in the chapter on diagnosing cardiac 
device IE, the authors recognize the utility of SPECT-CT 
and PET-CT scanning as additional tools in difficult cases, 
such as in patients with suspected LDIE, positive blood 
cultures and negative echocardiography (Class IIb, level 
of evidence C).4 Erba et al. showed that SPECT-CT allowed 
LDIE to be confirmed or reliably excluded device-associated 
infections during febrile episodes and sepsis, with 95% nega-
tive predictive value (NPV).5
The aim of the present study was to show the diagnos-
tic value of SPECT-CT in patients with an intracardiac 
mass (ICM) suspected of being vegetation, in comparison 
to the gold standard modified Duke criteria (MDC).
Material and methods
The prospective registry included consecutive patients 
with ICMs on the lead admitted to a reference university 
center (Department of Electrocardiology, John Paul II Hos-
pital, Kraków, Poland) from August 2014 to August 2017. 
The prerequisites for including a patient in the study were: 
detection of an ICM on echocardiography and provision 
of informed consent to participate in the study. Confirma-
tion or rejection of an LDIE diagnosis was made according 
to the algorithm used in our center and based on the MDC, 
which is considered the gold standard (Fig. 1). Among the pa-
tients, there was a variety of clinical presentations and vari-
ous degrees of clinical IE suspicion (Table 1). A final diagnosis 
of LDIE according to the MDC was established after collect-
ing all the tests included in the major and minor criteria. All 
the patients also underwent SPECT-CT scanning.
The cohort was divided into 2 groups: patients with 
definite and possible LDIE diagnoses based on the MDC 
(the  LDIE-positive group), and  patients with negative 
Fig. 1. The diagnostic algorithm for the diagnosis of lead-dependent 
infective endocarditis (LDIE) based on the modified Duke criteria (MDC). 
Y – yes, N – no; typical blood cultures: blood cultures for microorganisms 
consistent with infective endocarditis (IE) from 2 or more separate 
cultures of blood were treated as major criterion; microbiological 
evidence: positive blood culture but does not meet major criterion, more 
than 1 positive blood culture with skin bacteria was treated as a minor 
criterion, 1 positive blood culture with skin bacteria was treated as sample 
contamination; local infection: signs of inflammation of the pocket 
of the cardiac device or pocket skin erosion with purulent drainage; 
septic pulmonary embolism: clinical, echocardiographic and laboratory 
features of pulmonary embolism accompanied by evidence of recurrent 
pulmonary infections
PM – pacemaker; ICD – implantable cardioverter-defibrillator;  
CRT – cardiac resynchronization therapy.
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LDIE diagnoses according to the MDC (the LDIE-nega-
tive group). Both groups included patients with positive 
and negative SPECT-CT results. The diagnostic test evalu-
ated in the present study was SPECT-CT, which was com-
pared with the gold standard MDC.
Approval to conduct the study was obtained from the lo-
cal ethics committee.
SPECT-CT as a diagnostic modality
In our center, the autologous leukocyte labeling proce-
dure was performed in strict accordance with the Society 
of Nuclear Medicine Procedure Guidelines.6 Whole-body 
scans followed by chest SPECT-CT scans were acquired 6 h 
and 24 h after the injection of radioisotope-labeled white 
blood cells (WBCs) with the use of a Symbia T16 SPECT-CT 
gamma camera system (Siemens AG, Munich, Germany). 
The first 10 patients underwent SPECT-CT with Scinti-
mun® (Cisbio, Codolet, France) and subsequent patients 
with 99mTc-HMPAO (GE Healthcare Ltd., Amersham, 
UK). The transmission data were reconstructed using fil-
tered back projection to produce cross-sectional images. 
The resolution of  the computed tomography (CT) scan 
was 2.5 mm, and localization images were produced with 
a 4.5-mm pixel size, similar to nuclear medicine emission 
images. The CT scans were reconstructed onto a 256 × 256 
matrix. The SPECT component of the same field of view 
was acquired using a  128 × 128 matrix, 360° rotation, 
6° angle step, and acquisition time of 25 s per frame. Both 
attenuation-corrected CT and noncorrected SPECT images 
were evaluated in the coronal, transaxial and sagittal plane 
modes. All the studies were evaluated by 2 experienced 
nuclear medicine specialists. Scintigraphy was considered 
positive for CDRIE when an area of labeled WBCs uptake 
superior to the background activity was identified in the in-
volved area and when the signal increased over time (Fig. 2).7
Statistical analysis
The statistical analysis was performed using the STA-
TISTICA v. 12.5 data analysis software system (StatSoft 
Inc., Tulsa, USA). For quantitative variables, minimum, 
maximum, mean, and standard deviation (SD) values were 
provided. The results of the tests were expressed as a 2-way 
contingency table. The assessment of the tests included 
the following parameters: sensitivity, specificity, positive 
predictive value (PPV), negative predictive value (NPV), 
accuracy, likelihood ratio for a positive test result (LR+), 
and likelihood ratio for a negative test result (LR–).
The interpretation of the  likelihood ratios (LRs) was 
performed according to Attia.8 A test has real diagnostic 
utility if the LR is ≥10 or ≤0.1. Values between 5 and 10 
and between 0.1 and 0.2 show that a test is moderately 
useful. An LR between 0.5 and 2 indicates that the test has 
no diagnostic value.9 Inter-observer variability was calcu-
lated using multi-rater Cohen’s kappa (κ) statistics with 
Table 1. Indications for echocardiography in consecutive patients  
with ICM: clinical presentation, diagnosis based on the Duke criteria 
and the results of SPECT-CT studies
Patient 
No.
Clinical 
presentation
Diagnosis 
of LDIE based 
on Duke criteria
SPECT-CT 
heart
SPECT-CT 
pocket
1. A N N N
2. B D N P
3. C D N N
4. DT N N N
5. DT N N N
6. A N N N
7. A Ps P N
8. A Ps P N
9. B D N N
10. A D P N
11. C D P N
12. A Ps P N
13. B D P N
14. A N P P
15. A N P N
16. A N N N
17. C D P N
18. DT N N N
19. A N N N
20. C D P N
21. E Ps N N
22. A N P N
23. A N N N
24. A Ps P N
25. A Ps P N
26. B D N N
27. DT N P N
28. A N N N
29. DT N N N
30. A N N N
31. E Ps P N
32. E N N N
33. C D P N
34. A N N N
35. A N N N
36. B D P P
37. DT N N N
38. E Ps P P
39. A N N N
40. A N N N
A – diagnostic work-up of dyspnoea and/or heart failure; B – diagnostic work-up 
prior to transvenous lead extraction due to pocket infection; C – diagnostic 
work-up of sepsis; DT – diagnostic work-up prior to transvenous lead extraction 
due to lead dysfunction/system change/system upgrade; E – diagnostic work-up 
of fever; N – negative; P – positive; Ps –possible; D – definite; ICM – intracardiac 
mass; LDIE – lead-dependent infective endocarditis; SPECT-CT – single-photon 
emission computed tomography with conventional computed tomography.
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a 95% confidence interval (CI). The definitions presented 
by Landis and Koch were used to evaluate the strength 
of  the  rater agreement and  were categorized as  slight 
(0–0.20); fair (0.21–0.40); moderate (0.41–0.60); substan-
tial (0.61–0.80); and almost perfect (0.81–1.00).10 A 2-tailed 
p-value <0.05 was considered significant.
Results
The study population consisted of 40 patients (7 fe-
males and 33 males), mean age 62.0 ±16.5 years (range: 
23.8–89.0), with different types of  CIEDs and  ICMs 
detected by transthoracic or transesophageal echocar-
diography (TTE/TEE). The patients were implanted with 
the following types of CIED: 19 had pacemakers, 12 had 
implantable cardioverter-defibrillators (ICD), 7 had un-
dergone cardiac resynchronization therapy (CRT), and 2 
had pacemakers and ICDs on both sides of the chest. Lead 
dwell time was 102.1 ±85.5 months (range: 0.6–434.1).
In the LDIE-positive group, there were 19 patients (3 fe-
male) with an average age of 72.6 ±8.9 years. Definite LDIE 
was diagnosed in 11 patients on the basis of at least 2 major 
criteria fulfilled: along with ICMs there was septic pulmo-
nary embolism in 6 patients and local infection in 5 patients. 
Two patients with definite LDIE had positive blood cultures 
Fig. 2. Single-photon emission computed tomography with conventional computed tomography (SPECT-CT) and chest X-ray in patients with negative 
and positive SPECT-CT results. A – Single-chamber implantable cardioverter-defibrillators (ICD) system. The SPECT-CT study with the use of 99mTc-HMPAO-
labeled leukocytes on the left side of the picture and chest X-ray picture on the right side. The negative result of the SPECT-CT study is presented 
in the upper and middle panels of the SPECT-CT figure. B – Dual-chamber pacemaker (DDD) pacing system. SPECT-CT study with the use of 99mTc-HMPAO-
labeled leukocytes on the left side of the picture and chest X-ray picture on the right side. Positive result suggesting infective endocarditis (IE) is presented 
in the upper and middle panels of the SPECT-CT figure. Focal uptake observed in the right atrium and partially in the right ventricle near the lead (arrows)
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for Staphylococcus aureus, thus meeting a major Duke crite-
rion. Possible LDIE was diagnosed in 8 patients in the pres-
ence of 1 major and 1 minor criterion (Table 1). The major 
Duke criterion in each of these patients was an ICM; the mi-
nor criteria were fever in 6 patients and positive blood cul-
tures that did not meet the major Duke criterion in 2 patients.
In the LDIE-negative group, there were 21 patients (4 fe-
male) with an average age of 57.9 ±21.8 years. When compared 
with the MDC results, the results obtained by SPECT-CT 
were true positive (TP) in 14 patients, false negative (FN) 
in 5, false positive (FP) in 4, and true negative (TN) in 17 
patients. The  SPECT-CT results were FN in  5 patients 
in whom antibiotic treatment had been administered before 
the examination. Based on the number of patients with TP, 
FN, FP, and TN results, the diagnostic value of SPECT-CT 
in relation to MDC was calculated (Table 2). Diagnostic test 
using SPECT-CT showed high sensitivity, specificity and ac-
curacy (73.7%, 81.0% and 77.5%, respectively) and high PPV 
and NPV (PPV 77.8% and NPV 77.3%). The scintigraphic test 
can be useful to diagnose or rule out LDIE (LR+ = 3.868, 
LR– = 0.325). Agreement between the 2 tests was moderate 
but statistically significant (κ = 0.548, p < 0.001), according 
to Landis and Koch.10
After the exclusion of the 5 patients undergoing antibiot-
ic treatment at the time of the examination, the SPECT-CT 
test sensitivity, accuracy and NPV significantly increased 
Table 2. The diagnostic value of SPECT-CT in relation to MDC
Parameter Test based on SPECT-CT
Sensitivity
result 73.7%
95% CI 55.1–86.1%
Specificity
result 81.0%
95% CI 64.2–92.2%
PPV
result 77.8%
95% CI 58.2–90.9%
NPV
result 77.3%
95% CI 61.3–88.0%
ACC
result 77.5%
95% CI 59.9–89.3%
LR+
result 3.868
95% CI 1.539–11.065
LR−
result 0.325
95% CI 0.150–0.699
κ
κ 0.548
SE 0.133
95% CI 0.193–0.785
Z 3.447
p-value <0.001
CI – confidence interval; PPV – positive predictive value; NPV – negative 
predictive value; ACC – accuracy; LR+ – likelihood ratio for a positive test 
result; LR− – likelihood ratio for a negative test result; MDC – modified 
Duke criteria; SPECT-CT – single-photon emission computed tomography 
with conventional computed tomography; κ – multi-rater Cohen's kappa; 
SE – standard error; Z – z-score.
Table 3. The diagnostic value of SPECT-CT for MDC after exclusion 
of 5 patients with false negative (FN) results due to ongoing antibiotic 
treatment at the time of the SPECT-CT
Parameter Test based on SPECT-CT
Sensitivity
result 100.0%
95% CI 79.0–100.0%
Specificity
result 81.0%
95% CI 67.0–81.0%
PPV
result 77.8%
95% CI 61.5–77.8%
NPV
result 100.0%
95% CI 82.7–100.0%
ACC
result 88.6%
95% CI 71.8–88.6%
LR+
result 5.250
95% CI 2.391–5.250
LR−
result 0.000
95% CI 0.000-0.313
κ
κ 0.773
SE 0.107
95% CI 0.439–0.773
Z 4.598
p-value <0.001
CI – confidence interval; PPV – positive predictive value; NPV – negative 
predictive value; ACC – accuracy; LR+ – likelihood ratio for a positive test 
result; LR− – likelihood ratio for a negative test result; MDC – modified 
Duke criteria; SPECT-CT – single-photon emission computed tomography 
with conventional computed tomography; κ – multi-rater Cohen's kappa; 
SE – standard error; Z – z-score. 
to 100%, 88.6% and 100%, respectively (Table 3). Further-
more, LR+ amounted to 5.250 and LR− reached 0; agree-
ment between the 2 tests improved to almost perfect con-
cordance (κ = 0.773, p < 0.001).10
Discussion
The detection of an ICM in a patient with indwelling 
endocardial leads requires a complete diagnostic workup 
to identify or exclude infection of the endocardium. A lack 
of other symptoms of inflammation leaves clinicians in un-
certainty, because LDIE can have an oligosymptomatic 
course and non-characteristic symptoms.11 On the other 
hand, the  presence of  an  implanted lead can promote 
thrombus formation.12,13 Therefore, accurate clinical judg-
ment is necessary to detect pulmonary embolism caused 
by uninfected lead-related thrombi, which should not be 
considered the major Duke criterion of LDIE.
The available literature supplies vast evidence of the dif-
ficulties in real-world clinical practice regarding diagnos-
ing IE in patients with CIEDs using the MDC.
Polewczyk et al., conducting research in a single patient 
cohort, did not differentiate definite from possible LDIE 
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in one study, but introduced this division in a subsequent 
report.14,15 In the first study, the authors used their own 
modification of the Duke criteria to allow for a diagnosis 
of definite LDIE when 1 major and 2 minor criteria were 
satisfied. In the subsequent study, they used the criteria 
proposed by the ESC; however, the total number of di-
agnosed IE cases did not change. Furthermore, the au-
thors did not provide information on the method used 
to diagnose LDIE in 1/3 of the patients without vegetation 
in the assessed group of 500 patients; however, they drew 
significant conclusions about the different mechanisms 
of LDIE development in these patients.16
We presented the diagnostic scheme adopted in our 
institution to confirm possible and definite LDIE in pa-
tients with CIEDs using the MDC. The detection of LDIE 
based on this interpretation of the Duke criteria, the gold 
standard of IE diagnosis, allowed us to evaluate the utility 
of using an accessory imaging modality such as SPECT-CT 
in the diagnostic workup of LDIE. A high correlation was 
observed in the results obtained using the 2 tests in the di-
agnosis of LDIE. In 5 patients with definite LDIE diagnoses 
who had received antibiotic treatment before admission 
to our institute, the SPECT-CT result was FN. Similar 
observations have been reported in the literature. The ini-
tiation of antimicrobial treatment before the termination 
of the diagnostic workup was the probable cause of the FN 
results of SPECT-CT and PET.17,18
The primary difficulty we encountered when attempting 
to compare our observations with other reports on pa-
tients referred for TLE procedures is the lack of consistency 
in the application of the Duke criteria in real-world clini-
cal practice. In a French study, the authors acknowledged 
a positive lead culture and permanently positive bacterial 
culture with pathogens not consistent with IE as the major 
microbiological Duke criterion, which is discordant with 
ESC guidelines.17
We demonstrated the high sensitivity, specificity and ac-
curacy of SPECT-CT scans in LDIE diagnosis (73.7%, 81.0% 
and 77.5%, respectively), with high positive and negative 
predictive values (77.8% and 77.3%, respectively). Our out-
comes differed from the results obtained by positron emis-
sion tomography (PET) testing in a study by Cautela et al., 
who reported significantly lower sensitivity and specific-
ity in LDIE detection (30.8% and 62.5%, respectively).17 
The discrepancy in the reported results of diagnostic tests 
might have been due to the adoption of different crite-
ria to diagnose LDIE. A recent meta-analysis of 6 studies 
using fluorine-18-fluorodeoxyglucose positron emission 
tomography/computed tomography (18F-FDG PET-CT) 
reported a pooled sensitivity of 65% and specificity of 88% 
for lead-dependent CIED infections, which concurs with 
our results.19
In  our cohort, the  agreement between SPECT-CT 
and MDC results according to Landis and Koch was mod-
erate, but statistically significant.10 Importantly, when ana-
lyzing patients who had not been treated with antibiotics 
before SPECT-CT, the  agreement between the  2 tests 
was almost perfect. The scintigraphic test can be useful 
to diagnose or rule out LDIE (LR+ = 3.868, LR– = 0.325). 
The implementation of SPECT-CT in the ESC guidelines 
has enabled precise diagnoses in  difficult cases, such 
as  in patients with isolated ICMs, and helped to avoid 
the  risk of  serious complications associated with TLE 
procedures.
Conducting a single imaging test is an advantage of us-
ing SPECT-CT, whereas diagnostic evaluation using 
the MDC requires multiple blood cultures and TTE/TEE 
assessments.
One limitation of  the  present study is  the  relatively 
small sample size; however, the results did not differ sig-
nificantly from other similar reports.19 The radiotracer 
used in SPECT-CT was not uniform in the whole cohort: 
the  first 10 patients underwent assessment with Scin-
timun® and  subsequent patients with 99mTc-HMPAO. 
These 2 methods have not been compared in the diagnosis 
of IE, but in the authors’ opinion, the use of 2 radiotracers 
did not add much bias, because only information about 
positive or negative results was taken into consideration. 
However, a multicenter phase III clinical trial comparing 
Scintimun® and 99mTc-HMPAO in diagnosing peripheral 
bone infections provided evidence of  good agreement 
between the 2 methods and of the efficacious diagnostic 
ability of both tracers to differentiate infection from sterile 
inflammation.20
Conclusions
Single-photon emission computed tomography with 
conventional CT with radioisotope-labeled leukocytes 
is a useful, efficient, single-step test for LDIE diagnosis 
with high sensitivity and specificity, and a satisfactory 
overall predictive value of over 77%.
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